Allocates capital across growth-stage technology and healthcare via direct equity and structured secondaries, with emphasis on revenue-generating startups and repeat founders. Matthew Riley brings operating experience from senior roles at software companies and has led deal sourcing, diligence and portfolio operations for institutional investors. Active in co-investments and follow-on rounds, the profile suits LPs seeking concentrated exposure to founder-led companies with operational engagement and exit-focused governance.
Allocates capital across growth-stage technology and healthcare via direct equity and structured secondaries, with emphasis on revenue-generating startups and repeat founders. Matthew Riley brings operating experience from senior roles at software companies and has led deal sourcing, diligence and portfolio operations for institutional investors. Active in co-investments and follow-on rounds, the profile suits LPs seeking concentrated exposure to founder-led companies with operational engagement and exit-focused governance.
Targets growth-stage technology and healthcare companies with repeat founders, prioritizing revenue-generating businesses and clear paths to liquidity. Capital allocation blends direct equity, structured secondaries and disciplined follow-ons to concentrate high-conviction positions while reserving capital for add-on rounds. Investment horizon is multi-year, exit-oriented with active operational engagement to accelerate go-to-market and unit economics. Underwriting emphasizes founder quality, defensible product-market fit, measurable revenue traction and governance that aligns incentives for scaling and exit.
Targets growth-stage technology and healthcare companies with repeat founders, prioritizing revenue-generating businesses and clear paths to liquidity. Capital allocation blends direct equity, structured secondaries and disciplined follow-ons to concentrate high-conviction positions while reserving capital for add-on rounds. Investment horizon is multi-year, exit-oriented with active operational engagement to accelerate go-to-market and unit economics. Underwriting emphasizes founder quality, defensible product-market fit, measurable revenue traction and governance that aligns incentives for scaling and exit.
| Trades 953 | Longs Won 697/953 73% | Profit Factor 23.32 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $247,759.01 |
| Average Win $58,012.85 | Best Trade (Aug 14) $5.58M | Sharpe Ratio -16.74 |
| Average Loss -$6,772.86 | Worst Trade (Aug 19) -$151,628.1 | Z-Score 17.33 (100%) |
| Commissions $0 | Avg. Trade Length 9m 3d | Expectancy $40,609.77 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 25,000 | 22,500 | 20,000 | 17,500 | 15,000 | 12,500 | 10,000 | 7,500 | 5,000 | 2,500 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAL American Airlines Group Inc. | 1,500 | $16,110 | $22,905 | - | $6,795 | 42.18% | -1.037% |
AAPL Apple Inc. | 10,717 | $2.65M | $3.31M | - | $658,521.03 | 24.83% | -7.354% |
ABBV AbbVie Inc. | 974 | $225,519.5 | $244,415.56 | - | $18,896.06 | 8.38% | -2.513% |
ABNB Airbnb, Inc. | 1,166 | $148,503.53 | $176,672.32 | - | $28,168.79 | 18.97% | -0.368% |
ABT Abbott Laboratories | 1,449 | $148,769 | $153,159.3 | - | $4,390.3 | 2.95% | +0.085% |
ACHR Archer Aviation Inc. | 1,611 | $8,329 | $7,475.04 | - | -$853.96 | -10.25% | -2.11% |
ACN Accenture plc Class A | 207 | $41,046 | $34,345.44 | - | -$6,700.56 | -16.32% | +1.611% |
ADM Archer-Daniels-Midland Co | 24,166 | $1.22M | $1.92M | - | $694,610.84 | 56.89% | -1.662% |
ADP Automatic Data Processing Inc. | 532 | $108,091.92 | $141,756.71 | - | $33,664.79 | 31.14% | +0.982% |
AEP American Electric Power Company, Inc. | 354 | $46,402 | $45,258.9 | - | -$1,143.1 | -2.46% | +0.055% |
AFL Aflac Inc. | 195 | $21,393 | $24,858.6 | - | $3,465.6 | 16.2% | +0.094% |
AGG iShares Core U.S. Aggregate Bond ETF | 29,720 | $2.88M | $2.89M | - | $12,975.5 | 0.45% | -0.256% |
AKRE Akre Focus ETF | 108 | $5,708 | $6,208.92 | - | $500.92 | 8.78% | -0.087% |
ALL Allstate Corporation | 1,638 | $315,789.91 | $432,563.02 | - | $116,773.11 | 36.98% | -0.49% |
ALLE Allegion plc | 273 | $39,664 | $42,970.2 | - | $3,306.2 | 8.34% | +0.216% |
AMAT Applied Materials, Inc. | 28 | $9,570 | $14,214.76 | - | $4,644.76 | 48.53% | +1.176% |
AMD Advanced Micro Devices, Inc. | 100 | $20,343 | $47,615 | - | $27,272 | 134.06% | -1.904% |
AMGN Amgen Inc. | 1,004 | $261,682.6 | $386,700.64 | - | $125,018.04 | 47.77% | -0.64% |
AMP Ameriprise Financial, Inc. | 935 | $497,822.42 | $510,360.43 | - | $12,538.01 | 2.52% | +0.253% |
AMZN Amazon.com Inc | 6,725 | $1.46M | $1.83M | - | $363,386.71 | 24.84% | +15.321% |